|
Volumn 57, Issue 9, 2002, Pages 595-601
|
Rabeprazole: Pharmacokinetics and pharmacokinetic drug interactions
a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ALUMINUM MAGNESIUM HYDROXIDE;
ANTACID AGENT;
CYTOCHROME P450 2C19;
CYTOCHROME P450 2D6;
CYTOCHROME P450 3A4;
DIAZEPAM;
DIGOXIN;
KETOCONAZOLE;
NORDAZEPAM;
PHENYTOIN;
PROTON PUMP INHIBITOR;
RABEPRAZOLE;
THEOPHYLLINE;
WARFARIN;
ADULT;
AREA UNDER THE CURVE;
DOSE RESPONSE;
DRUG ABSORPTION;
DRUG BIOAVAILABILITY;
DRUG BLOOD LEVEL;
DRUG ELIMINATION;
DRUG HALF LIFE;
DRUG METABOLISM;
FEMALE;
FOOD DRUG INTERACTION;
HUMAN;
HUMAN EXPERIMENT;
MALE;
NORMAL HUMAN;
REVIEW;
2-PYRIDINYLMETHYLSULFINYLBENZIMIDAZOLES;
ADULT;
AGING;
ANTI-ULCER AGENTS;
BENZIMIDAZOLES;
BIOLOGICAL AVAILABILITY;
CHILD;
CLINICAL TRIALS;
DRUG INTERACTIONS;
FEMALE;
FOOD-DRUG INTERACTIONS;
HUMANS;
INTESTINAL ABSORPTION;
MALE;
OMEPRAZOLE;
|
EID: 0036712557
PISSN: 00317144
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
Times cited : (38)
|
References (42)
|